PGHL Stock Overview
Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Procter & Gamble Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5,219.80 |
| 52 Week High | ₹5,642.85 |
| 52 Week Low | ₹4,636.55 |
| Beta | 0.50 |
| 11 Month Change | 0.59% |
| 3 Month Change | 1.87% |
| 1 Year Change | 1.09% |
| 33 Year Change | -3.72% |
| 5 Year Change | 15.07% |
| Change since IPO | 1,238.58% |
Recent News & Updates
Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Sep 28
Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Aug 27Recent updates
Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Sep 28Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Aug 27Earnings Not Telling The Story For Procter & Gamble Health Limited (NSE:PGHL)
Jun 08Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)
Feb 14Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00
Sep 29Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 10Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)
Mar 30We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right
Nov 17Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50
Oct 23Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50
Oct 09Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit
Feb 16Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?
Oct 04Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock
May 10Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?
Mar 23Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 02Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?
Jan 31Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like
Jan 10
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?
Dec 19Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 01Shareholder Returns
| PGHL | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.3% | -0.8% | -0.9% |
| 1Y | 1.1% | 60.3% | 39.7% |
Return vs Industry: PGHL underperformed the Indian Pharmaceuticals industry which returned 60.3% over the past year.
Return vs Market: PGHL underperformed the Indian Market which returned 39.7% over the past year.
Price Volatility
| PGHL volatility | |
|---|---|
| PGHL Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: PGHL has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: PGHL's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,407 | Milind Thatte | www.pghealthindia.com |
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands.
Procter & Gamble Health Limited Fundamentals Summary
| PGHL fundamental statistics | |
|---|---|
| Market cap | ₹86.62b |
| Earnings (TTM) | ₹2.01b |
| Revenue (TTM) | ₹11.51b |
43.1x
P/E Ratio7.5x
P/S RatioIs PGHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PGHL income statement (TTM) | |
|---|---|
| Revenue | ₹11.51b |
| Cost of Revenue | ₹3.31b |
| Gross Profit | ₹8.21b |
| Other Expenses | ₹6.20b |
| Earnings | ₹2.01b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 04, 2024
| Earnings per share (EPS) | 121.08 |
| Gross Margin | 71.29% |
| Net Profit Margin | 17.46% |
| Debt/Equity Ratio | 0% |
How did PGHL perform over the long term?
See historical performance and comparisonDividends
2.3%
Current Dividend Yield91%
Payout RatioDoes PGHL pay a reliable dividends?
See PGHL dividend history and benchmarks| Procter & Gamble Health dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2024 |
| Dividend Pay Date | Jan 04 2025 |
| Days until Ex dividend | 38 days |
| Days until Dividend pay date | 75 days |
Does PGHL pay a reliable dividends?
See PGHL dividend history and benchmarks